10-Year Results of a Phase III Randomized Trial of High-Dose Radiotherapy and Risk-Adapted Androgen Deprivation in Localized Prostate Cancer

被引：0
|
作者：
Zapatero, A. [1 ]
Guerrero Grande, A. D. [2 ]
Maldonado, X., Sr. [3 ]
Alvarez, A. [4 ]
San Segundo, C. Gonzalez [4 ]
Cabeza, M. A. [5 ]
Sole, J. M. [6 ]
Pedro Olive, A. [7 ]
Casas Duran, F. [8 ]
Boladeras, A. [9 ]
Martin de Vidales, C. [1 ]
Vazquez de la Torre, M. L. [10 ]
Varas, S. [11 ]
Calvo, F. A. [12 ]
机构：
[1] Hosp Univ Princesa, Madrid, Spain
[2] Hosp Univ Son Espases, Dept Radiat Oncol, Palma de Mallorca, Spain
[3] Hosp Univ Vall dHebron, Barcelona, Spain
[4] Hosp Univ Gregorio Maron, Madrid, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Hosp Gen Cataluna, Barcelona, Spain
[7] Hosp Plato, Barcelona, Spain
[8] Hosp Clin Barcelona, Barcelona, Spain
[9] LHosp, Catalan Inst Oncol, Dept Radiat Oncol, Barcelona, Spain
[10] Hosp Meixoeiro, Vigo, Spain
[11] Apices Data Management & Biostatist Ctr, Madrid, Spain
[12] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
149
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [21] Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial
    Nabid, Abdenour
    Carrier, Nathalie
    Vigneault, Eric
    Thu Van Nguyen
    Vavassis, Peter
    Brassard, Marc-Andre
    Bahoric, Boris
    Archambault, Robert
    Vincent, Francois
    Bettahar, Redouane
    Wilke, Derek
    Souhami, Luis
    EUROPEAN JOURNAL OF CANCER, 2021, 143 : 64 - 74
  • [22] Sexual outcomes in high risk prostate cancer treated with long term androgen deprivation therapy and radiotherapy: results from a phase III trial
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Souhami, Luis
    Duclos, Marie
    Vincent, Francois
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Lemaire, Celine
    QUALITY OF LIFE RESEARCH, 2016, 25 : 36 - 36
  • [23] Phase II trial of external radiotherapy, brachytherapy, androgen deprivation and docetaxel chemotherapy for high-risk, localized prostate cancer
    DiBiase, SJ
    Dawson, N
    Kwok, Y
    Kataria, R
    Hussain, A
    Nagda, S
    Bangalore, M
    Amin, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S296 - S297
  • [24] Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Report on Late Toxicity from DART 01/05 Randomized Phase III Trial
    Zapatero, A.
    Guerrero, A. D.
    Maldonado, J.
    Alvarez, A.
    Gonzalez San Segundo, C.
    Cabeza Rodriguez, M. D. L. A.
    Macias, V.
    Pedro, A.
    Casas, F.
    Boladeras, A.
    Martin de Vidales, C.
    Vazquez de la Torre, M. L.
    Calvo, F. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S139 - S140
  • [25] Reply to Leonard P. Bokhorst and Berdine L. Heesterman's Words of Wisdom re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3Randomised, Controlled Trial. Eur Urol. 2022;82:441
    Zapatero, Almudena
    Calvo, Felipe A.
    San-Segundo, Carmen Gonzalez
    Alvarez, Ana
    EUROPEAN UROLOGY, 2022, 82 (06) : E177 - E178
  • [26] High-risk prostate cancer: combination of high-dose, high-precision radiotherapy and androgen deprivation therapy
    Bolla, Michel
    Verry, Camille
    Long, Jean-Alexandre
    CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 349 - 354
  • [27] Prognostic value of testosterone following androgen deprivation and high-dose radiotherapy in prostate cancer
    Zapatero, A.
    Guerrero, A.
    Maldonado, X.
    Alvarez, A.
    Gonzalez San Segundo, C.
    Cabeza Rodriguez, M. A.
    Martin de Vidales, C.
    Sole, J. M.
    Pedro Olive, A.
    Casas, F.
    Boladeras, A.
    Vazquez de la Torre, M. L.
    Calvo, F. A.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S251 - S252
  • [28] <bold>Long-term versus short-term androgen deprivation combined </bold>with high-dose radiotherapy for localized prostate cancer: A Spanish multicenter phase III trial.
    Zapatero, A.
    Guerrero, A.
    Maldonado, X.
    Alvarez, A.
    Gonzalez San Segundo, C.
    Cabeza, A.
    Macias, V.
    Casas, F.
    Pedro-Olive, A.
    Calvo, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer
    McKay, Rana R.
    Xie, Wanling
    Ye, Huihui
    Fennessy, Fiona M.
    Zhang, Zhenwei
    Lis, Rosina
    Calagua, Carla
    Rathkopf, Dana
    Laudone, Vincent P.
    Bubley, Glenn J.
    Einstein, David J.
    Chang, Peter K.
    Wagner, Andrew A.
    Parsons, J. Kellogg
    Preston, Mark A.
    Kilbridge, Kerry
    Chang, Steven L.
    Choudhury, Atish D.
    Pomerantz, Mark M.
    Trinh, Quoc-Dien
    Kibel, Adam S.
    Taplin, Mary-Ellen
    JOURNAL OF UROLOGY, 2021, 206 (01): : 80 - 87
  • [30] 10-Year-Results of the prospective German-Austrian Phase II Multicenter study for risk-adapted Radiotherapy of localized Prostate Cancer with a moderate Dose Escalation from 70 to 74 Gy
    Goldner, G.
    Bombosch, V.
    Becker, G.
    Wachter, S.
    Glocker, S.
    Feldmann, H.
    Bamberg, M.
    Poetter, R.
    Molls, M.
    Geinitz, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 37 - 38
12345